BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+0.66%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$167M
AUM Growth
+$167M
Cap. Flow
+$4.56M
Cap. Flow %
2.73%
Top 10 Hldgs %
72.22%
Holding
63
New
9
Increased
5
Reduced
4
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARVN icon
26
Arvinas
ARVN
$568M
$1.16M 0.69%
15,000
ETRN
27
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.13M 0.68%
133,050
CORT icon
28
Corcept Therapeutics
CORT
$7.35B
$1.1M 0.66%
50,000
OVV icon
29
Ovintiv
OVV
$10.8B
$1.08M 0.64%
34,200
-150
-0.4% -$4.72K
SLNO icon
30
Soleno Therapeutics
SLNO
$3.6B
$1M 0.6%
876,899
BHVN
31
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$971K 0.58%
10,000
BIOR
32
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$964K 0.58%
270,000
KALV icon
33
KalVista Pharmaceuticals
KALV
$678M
$958K 0.57%
40,000
PGNY icon
34
Progyny
PGNY
$2.04B
$885K 0.53%
15,000
CFRX
35
DELISTED
ContraFect Corporation
CFRX
$880K 0.53%
200,000
GTHX
36
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$878K 0.53%
40,000
TBIO
37
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$826K 0.49%
30,000
NARI
38
DELISTED
Inari Medical, Inc. Common Stock
NARI
$653K 0.39%
7,000
TPTX
39
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$624K 0.37%
+8,000
New +$624K
PXD
40
DELISTED
Pioneer Natural Resource Co.
PXD
$618K 0.37%
3,800
TGTX icon
41
TG Therapeutics
TGTX
$4.65B
$582K 0.35%
15,000
AWH
42
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$579K 0.35%
103,104
APLS icon
43
Apellis Pharmaceuticals
APLS
$3.48B
$506K 0.3%
8,000
STOK icon
44
Stoke Therapeutics
STOK
$1.08B
$505K 0.3%
15,000
PTGX icon
45
Protagonist Therapeutics
PTGX
$3.67B
$449K 0.27%
10,000
ZNTL icon
46
Zentalis Pharmaceuticals
ZNTL
$122M
$426K 0.25%
+8,000
New +$426K
XNCR icon
47
Xencor
XNCR
$580M
$424K 0.25%
12,300
LSF icon
48
Laird Superfood
LSF
$61.7M
$418K 0.25%
14,000
CCXI
49
DELISTED
ChemoCentryx, Inc.
CCXI
$402K 0.24%
30,000
AKBA icon
50
Akebia Therapeutics
AKBA
$833M
$379K 0.23%
+100,000
New +$379K